Skip Navigation

A Phase II Study of ZEN003694 in Combination with Talazoparib in Patients with Triple-Negative Breast Cancer

Brief Summary

Type:
Breast Cancer

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT03901469

Study #:
STUDY00143837

Start Date:
Aug 01, 2019

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03901469

View Complete Trial Details & Eligibility at ClinicalTrials.gov